What must Dermani Medspa's Business Associate do to mitigate the harmful effects of a PHI disclosure?

According to Dermani Medspa's 2025 Franchise Disclosure Document, a Business Associate must mitigate, to the extent practicable, any harmful effect that is known to the Business Associate of a use or disclosure of PHI (Protected Health Information) in violation of the requirements of the agreement. This obligation is part of the HIPAA (Health Insurance Portability and Accountability Act) compliance measures that Dermani Medspa requires of its Business Associates.

In practical terms, this means that if a Dermani Medspa franchisee, acting as a Business Associate, discovers that PHI has been used or disclosed improperly, they must take action to minimize the damage. The FDD does not specify the exact steps for mitigation, as these would likely depend on the nature and extent of the unauthorized disclosure. However, the franchisee is expected to take reasonable and feasible steps to address the situation.

This requirement highlights the importance of data protection and privacy within the Dermani Medspa franchise system. Franchisees must be vigilant in protecting patient information and responsive in addressing any breaches. Failure to adequately mitigate the harmful effects of a PHI disclosure could lead to legal and financial repercussions for the franchisee and the Dermani Medspa brand. Franchisees should consult with legal counsel to ensure they understand their obligations under HIPAA and the franchise agreement.